Home > Financial Ratios > CONCORD BIOTECH

CONCORD BIOTECH
Core EBITDA Growth

    Back to All Ratios
CONCORD BIOTECH is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for CONCORD BIOTECH
Please provide your vote to see the results

CONCORD BIOTECH Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 18.3121.3829.11-12.9944.86

What is the latest Core EBITDA Growth ratio of CONCORD BIOTECH ?

The latest Core EBITDA Growth ratio of CONCORD BIOTECH is 18.31 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202518.31
Mar202421.38
Mar202329.11
Mar2022-12.99
Mar202144.86

How is Core EBITDA Growth of CONCORD BIOTECH Trending?

Years Core EBITDA Growth % Change
Mar2025 18.31
-14.36
Mar2024 21.38
-26.55
Mar2023 29.11
Positive
Mar2022 -12.99
Negative
Mar2021 44.86 -

Other Financial Ratios of CONCORD BIOTECH


Compare Core EBITDA Growth ratio of peers of CONCORD BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CONCORD BIOTECH ₹17,328.6 Cr 4.5% 1.4% -15.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹384,469.0 Cr 0.5% -2.3% -12.5% Stock Analytics
DIVIS LABORATORIES ₹160,672.0 Cr 0.9% -0.8% 10.8% Stock Analytics
CIPLA ₹125,034.0 Cr -0.3% -0.9% -3.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹119,542.0 Cr -3% -2.4% 3.8% Stock Analytics
DR REDDYS LABORATORIES ₹108,571.0 Cr 0.6% 3.9% -0.4% Stock Analytics


CONCORD BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
CONCORD BIOTECH

4.5%

1.4%

-15.8%

SENSEX

1.2%

1.9%

-0.2%


You may also like the below Video Courses